Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relapse of AS Patients After Etanercept Withdrawal
NCT02915354Phase 4Completed
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2007
- Primary completion
- Sep 2010
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etanercept in ankylosing spondylitis (AS), sponsored by Sun Yat-sen University. Primary endpoint: Status of Relapse at 3 years. Started Jul 2007; status: completed.
02
Drugs
etanercept
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT02915354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02915354.